Shenzhen Chipscreen Biosciences Co., Ltd. (SHSE:688321) commences share repurchases on March 26, 2024, under the program mandated by the shareholders in the Extraordinary General Meeting held on February 22, 2024. As per the mandate, the company is authorized to repurchase to repurchase CNY 15 million worth of its common shares. The shares will be repurchased at a price of not more than CNY 28.47 per share.

The purpose of the program is to effectively safeguard the interests of shareholders, enhance investor confidence, and promote the company's stable and healthy development. The repurchased shares will be cancelled to reduce registered capital. The program will be funded out of the company's own or self-raised funds.

The program will be valid till 12 months from the date of approval by shareholders.